Research programme: gastrointestinal disorders therapy - Dimerix Bioscience/Starpharma
Alternative Names: G-Protein Coupled Receptor modulators research programme - Dimerix Bioscience/Starpharma; GPCR modulators research programme - Dimerix Bioscience/StarpharmaLatest Information Update: 14 Sep 2010
Price :
$50 *
At a glance
- Originator Dimerix Bioscience; Starpharma
- Class Dendrimers; Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 11 Oct 2005 Preclinical trials in Gastrointestinal disorders in Australia (unspecified route)